Moxcad CL

Moxcad-CL 625 Tablet is an oral antibacterial combination of amoxicillin and clavulanic acid. It is used to treat a wide range of bacterial infections. It is commonly prescribed to treat infections such as ear infections (otitis media), sinus infections (bacterial rhinosinusitis), respiratory infections (pneumonia, bronchitis), and skin and soft tissue infections (cellulitis, abscesses).

Since Moxcad-CL 625 Tablet is a penicillin-type antibiotic, individuals with a known penicillin allergy may be at higher risk of an allergic reaction. Patients who are allergic to penicillin or who have had a previous allergic reaction to Moxcad-CL 625 Tablet should not use it.

Moxcad-CL 625 Tablet should be used with caution in patients with liver disease or a history of jaundice. Dose adjustment may be needed. Your doctor will decide whether to prescribe this medicine after evaluating your condition, often with liver function tests. Always take it only after consulting your doctor.

As per the most recent evidence, Moxcad-CL 625 Tablet does not interfere with hormonal birth control. However, talk to your doctor if you have any concerns. They can help you feel confident and protected. Antibiotics such as Moxcad-CL 625 Tablet can cause nausea, vomiting, and diarrhea. If you vomit within two hours of taking the birth control pills, or if you have had diarrhea for 24 hours or more, your birth control pills may be ineffective. You may need to use an additional barrier method (such as condoms) in such cases.

No. It is very important to complete the full course of treatment, even if you start feeling better before finishing it. Feeling better does not necessarily mean that all the bacteria causing your infection have been eliminated. Stopping antibiotic treatment early may cause the symptoms to recur or make the bacteria resistant to the antibiotic.

Yes, diarrhea or loose motions is amongst the most commonly reported side effects of Moxcad-CL 625 Tablet. In most cases, this is mild and resolves once the antibiotic course is complete. If you develop severe diarrhea, bloody stools, or abdominal cramping, or if symptoms persist or worsen, inform your doctor immediately.

No. Moxcad-CL 625 Tablet is an antibiotic and works only against bacterial infections. Viruses cause the common cold and influenza (flu). Antibiotics are not effective against them. If you have a cold or flu, supportive care such as rest, staying hydrated, and using home remedies like saline gargles or steam inhalation may help with recovery.

Moxcad-CL 625 Tablet begins to work against bacterial infections within hours of taking it. However, it may take 24 to 48 hours to notice improvement in your symptoms. If you do not notice any improvement, or if your symptoms worsen at any point, contact your doctor. This may indicate that the bacteria causing the infection are resistant to this antibiotic or that a different treatment is needed.

Special care is needed when Moxcad-CL 625 Tablet is given to older adults, particularly those with reduced kidney function (renal impairment). The kidneys primarily clear Moxcad-CL 625 Tablet from the body, so if they are not functioning well, the drug can build up in the body and increase the risk of side effects. Dose adjustment may be required based on kidney function.

Amoxycillin + Clavulanic Acid is available as a dry powder (dry syrup) that needs to be mixed with water before use. Proper preparation and storage are essential to ensure the medicine works correctly. Always refrigerate the reconstituted suspension (2°C–8°C). Shake well before each use, and discard it within 7–10 days after reconstitution.

Moxcad-CL 625 Tablet fights infections caused by bacteria, specifically those that produce enzymes called beta-lactamases. These enzymes are a common mechanism by which bacteria defend themselves against antibiotics. Clavulanic acid blocks these enzymes, allowing amoxicillin to kill the bacteria effectively. This medicine is active against a broad range of bacteria, including both gram-positive and gram-negative types. Common bacteria it targets include Streptococcus pneumoniae (a cause of pneumonia and ear infections), Haemophilus influenzae (associated with respiratory and ear infections), and Moraxella catarrhalis (common in sinus and chest infections).